Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Share-based Compensation (2020 - 2026)

PROCEPT BioRobotics has reported Share-based Compensation over the past 7 years, most recently at $13.1 million for Q1 2026.

  • Quarterly Share-based Compensation rose 29.32% to $13.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $50.6 million through Mar 2026, up 41.68% year-over-year, with the annual reading at $47.6 million for FY2025, 49.51% up from the prior year.
  • Share-based Compensation was $13.1 million for Q1 2026 at PROCEPT BioRobotics, up from $10.8 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $14.5 million in Q3 2025 and troughed at $1.6 million in Q1 2022.
  • The 5-year median for Share-based Compensation is $6.3 million (2024), against an average of $7.2 million.
  • Year-over-year, Share-based Compensation soared 269.1% in 2022 and then grew 19.34% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $2.9 million in 2022, then soared by 72.65% to $5.0 million in 2023, then soared by 82.39% to $9.1 million in 2024, then increased by 19.34% to $10.8 million in 2025, then increased by 20.57% to $13.1 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Share-based Compensation are $13.1 million (Q1 2026), $10.8 million (Q4 2025), and $14.5 million (Q3 2025).